

Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|17|34|3786-3796
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.17, Iss.34, 2011-11, pp. : 3786-3796
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Neopterin as a Marker for Immune System Activation
Current Drug Metabolism, Vol. 3, Iss. 2, 2002-04 ,pp. :


Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 2, 2013-04 ,pp. :


Regulation of B-Cell Activation by Complement Receptors CD21 and CD35
Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. :


ALCAM (CD166) Is a Surface Marker for Early Murine Cardiomyocytes
Cells Tissues Organs, Vol. 184, Iss. 3-4, 2007-04 ,pp. :